Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Retained Earnings (2016 - 2025)

Icu Medical (ICUI) has disclosed Retained Earnings for 17 consecutive years, with $690.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings rose 595.61% year-over-year to $690.9 million, compared with a TTM value of $690.9 million through Dec 2025, up 595.61%, and an annual FY2025 reading of $690.9 million, up 595.61% over the prior year.
  • Retained Earnings was $690.9 million for Q4 2025 at Icu Medical, up from -$33.0 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $690.9 million in Q4 2025 and bottomed at -$165.7 million in Q3 2022.
  • Average Retained Earnings over 5 years is -$24.2 million, with a median of -$57.3 million recorded in 2023.
  • The sharpest move saw Retained Earnings crashed 9709.39% in 2023, then surged 595.61% in 2025.
  • Year by year, Retained Earnings stood at -$19.3 million in 2021, then plummeted by 320.25% to -$81.0 million in 2022, then soared by 34.45% to -$53.1 million in 2023, then crashed by 162.62% to -$139.4 million in 2024, then soared by 595.61% to $690.9 million in 2025.
  • Business Quant data shows Retained Earnings for ICUI at $690.9 million in Q4 2025, -$33.0 million in Q3 2025, and -$32.6 million in Q2 2025.